NuVasive, Inc. v. Renaissance Surgical Center North, L.P.

853 F. Supp. 2d 654, 2012 WL 531129, 2012 U.S. Dist. LEXIS 20612
CourtDistrict Court, S.D. Texas
DecidedFebruary 17, 2012
DocketCivil Action No. 11-cv-2897
StatusPublished
Cited by12 cases

This text of 853 F. Supp. 2d 654 (NuVasive, Inc. v. Renaissance Surgical Center North, L.P.) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NuVasive, Inc. v. Renaissance Surgical Center North, L.P., 853 F. Supp. 2d 654, 2012 WL 531129, 2012 U.S. Dist. LEXIS 20612 (S.D. Tex. 2012).

Opinion

MEMORANDUM AND ORDER

KEITH P. ELLISON, District Judge.

Pending before the Court is a Motion to Dismiss and/or to Strike filed by Third Party Defendants Electrodiagnostics LLC, Outpatient Spine Centers P.A., Saqib A. Siddiqui, and Woodlands Spine Centers P.A. (collectively, the “Third Party Defendants”) (Doc. No. 20). Also pending in this case is a Motion for Partial Summary Judgment filed by Defendant Renaissance Surgical Center North, L.P. (“Renaissance”) against the above Third-Party Defendants (Doc. No. 23). After considering the motions, all responses thereto, and the applicable law, the Court finds that both motions must be DENIED.

I. BACKGROUND

A. The Complaint

This case arises from the alleged failure of Defendants Renaissance and K & S Consulting ASC, L.P. (“K & S”) (collectively, the “Defendants”) to pay amounts owed to Plaintiff NuVasive, Inc. (“NuVasive”). NuVasive is a San Diego-based medical device company that designs, develops, and markets products for the surgical treatment of spine disorders. [656]*656(Compl. ¶ 1, Doc. No. 1.) Renaissance is the owner of an ambulatory surgical center (“ASC”) located in Humble, Texas. (Id. ¶ 2.)

At some point, NuVasive and Renaissance entered into a relationship through which NuVasive provided products for use by Renaissance surgeons. In its Complaint, NuVasive alleges that the business relationship between NuVasive and Renaissance is governed by NuVasive’s “Terms and Conditions of Sale.” (Compl. ¶¶ 16-17.) According to the Complaint, Renaissance began to fall behind in its payments for NuVasive devices at some point in 2009. (Id. ¶¶ 19-21.) NuVasive alleges that, from May 2009 to April 2010, Renaissance incurred an outstanding balance of $421,680.24, which it has refused to pay. (Id. ¶¶ 22-23.) In August 2011, NuVasive brought this suit against Renaissance, asserting claims for breach of contract, breach of the covenant of good faith and fair dealing, and goods sold and delivered at the agreed price. (Id. ¶¶ 27-39.)1 NuVasive also seeks attorneys’ fees and costs. (Id. ¶¶ 40-41.)

B. The Cross-Claim2

In September 2011, Renaissance filed an Answer to NuVasive’s Complaint, which included a Cross-Claim against the Third Party Defendants. (Countercl., Doc. No. 13.) Renaissance alleges that, in 2007, it entered into a series of agreements with Third Party Defendant Dr. Saqib A Siddiqui, under which Dr. Siddiqui was granted use rights to the ASC in order to perform medical services for his patients. (Id. ¶ 9.) Dr. Siddiqui initially entered these agreements by and through Woodlands Spine Centers, P.A. (“Woodlands”), and later by and through Outpatient Spine Centers, P.A. (“Outpatient”). (Id.) The Court hereinafter refers to these entities as the “Spine Centers,” and to the alleged contracts between Renaissance and these entities as the “ASC Use Agreements.” In general terms, Renaissance indicates, the agreement between the parties provided as follows: “In exchange for the right to use the ASC, its facilities, equipment, and staff for medical services, the Spine Centers [ ] agreed to pay Renaissance certain ‘use fees,’ plus 110% of the cost of all surgical implants provided by Renaissance and utilized by [Third Party Defendants] at the ASC, plus $300 for each case performed at the ASC.” (Id. ¶ 10.)

When Dr. Siddiqui first arrived at Renaissance, he made it clear that he had a preferred relationship with NuVasive, and he refused to cooperate with the ASC’s recommendation of alternative products. (Id. ¶ 11.) Although the ASC attempted to accommodate Dr. Siddiqui’s preferences, such accommodation became difficult by 2009, at which point “Renaissance began to see orders and extremely large invoices for NuVasive surgical implants and tools being used in Dr. Siddiqui’s cases.” (Id. ¶ 12.) Renaissance had difficulty recouping these costs from “certain insurance companies,” which resulted in a large balance owed by Renaissance to NuVasive, and “an even larger balance” owed to Renaissance by the Spine Centers. (Id.)

[657]*657Then, “[i]n an effort to control costs and to avoid the ballooning balances, Renaissance implemented new protocols for the ordering and use of NuVasive surgical tools and devices at its ASC.” (Id. ¶ 13.) These new protocols were discussed with Dr. Siddiqui and with a number of NuVasive representatives, including sales representative Bland Chamberlain IV. (Id.) The first new protocol established a cap on the amount of credit that Renaissance would agree to accept from NuVasive. Under this policy, NuVasive was not to deliver products if the current balance owed to NuVasive at the time of delivery was alleged by NuVasive to be more than $200,000. (Id.) NuVasive agreed to be bound by this protocol. The second protocol required NuVasive and the Spine Centers to give notice to Renaissance of any case in which NuVasive tools might be used, and to provide an estimate of the cost range for the NuVasive tools likely to be used in such a case. Renaissance was to pre-approve such costs, and to pre-pay the estimated cost before surgery took place. (Id. ¶ 14.)

According to Renaissance, Dr. Siddiqui and Mr. Chamberlain refused to abide by the new protocols, implementing NuVasive products in patients without authority or approval from the ASC. Mr. Chamberlain allegedly “repeatedly made products available to Dr. Siddiqui even though he knew that the [ASC] had made it clear that he was not to provide any tools unless they were pre-approved and pre-paid.” (Id. ¶ 15.) Renaissance alleges that Dr. Siddiqui’s frequent use of one NuVasive product in particular, “NeuroVision,” is at the root of this dispute. (Id. ¶¶ 16-18.)

Renaissance alleges that, unbeknownst and undisclosed to Renaissance at the time, Dr. Siddiqui and Mr. Chamberlain went into business together under the name “Electrodiagnostics LLC” (“Electro”). (Id. ¶ 19.) Renaissance alleges, upon information and belief, that Electro performed and billed for “neuro scanning services” performed on Dr. Siddiqui’s patents at the ASC. (Id.) Thus, Dr. Siddiqui and Mr. Chamberlain engaged in what Renaissance calls a “scam”: they pressured Renaissance to purchase NuVasive products on credit, because they had an independent and undisclosed financial interest in the use of NuVasive products. To hide this conduct, they did not assign the billing function for related “neuro scanning services” to NuVasive (as would have been the normal course of action under the agreement between Renaissance and the Third Party Defendants), but rather billed those services separately. (Id. ¶ 20.) Renaissance concludes that, had it known of the agreement between Dr. Siddiqui and Mr. Chamberlain, it would not have participated in the transactions at issue in NuVasive’s Complaint. (Id. ¶ 22.) Based upon the foregoing allegations, Renaissance asserts cross-claims against the Third Party Defendants for breach of contract, fraud in the inducement, and civil conspiracy. (Id. ¶¶ 24-35.)

C. The Pending Motions

The pending motions relate only to Renaissance’s Cross-Claim. The first is the Third Party Defendants’ motion to dismiss and/or strike Renaissance’s Cross-Claim.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
853 F. Supp. 2d 654, 2012 WL 531129, 2012 U.S. Dist. LEXIS 20612, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nuvasive-inc-v-renaissance-surgical-center-north-lp-txsd-2012.